In the past few weeks the EU Commission made several legislative proposals in the areas of chemistry/food safety and safety of (medical) products. Two of those topics we would...
Continue reading
Higher Regional Court, Frankfurt am Main, judgment dated 10 February 2022, Case No. 6 U 161/15 As reported here on
Continue reading
The Protocol on the Provisional Application of the UPCA entered into force on 19 January 2022 and the Unified Patent Court (UPC) was born as an international organisation. At ...
Continue reading
All articles
Proxygen, a leader in the discovery and development of molecular glue degraders, announced today that the company has entered into a strategic multi-year research collaboration and license agreement with Merck. Proxygen is eligible to receive up to €495 million ($554 milli...
Continue reading
Attractive, precision oncology therapy with long patent duration added to portfolioBlueprint Medicines to receive $175 million upfront and $165 million in potential milestone payments
Continue reading
Stada, Zentiva and four other generic drug companies can launch their generic products after Bayer withdrew its second application for a preliminary injunction to protect its cancer drug, Nexavar. But the companies could still face a costly damages claim if the court ultimat...
Continue reading
Maiwald in the press
We are very pleased to congratulate Dr Felix Schröter, Dr ...
Continue reading
Patent attorney Dr Ulrike Herr joins Maiwald as partner on 1 February 2022. Formerly with the Munich office of Isenb...
Continue reading
Maiwald, one of Germany’s leading IP law firms, has appointed
Continue reading
Staff News
The reach of Sec. 10(3) of the German Patent Act (GPA) has been the subject of debate by German patent courts for many years. Final clarification by the German Supreme Court i...
Continue reading
In the Special Report of Leaders League, Dr Christian Meyer explains how the new claim for compensation, based on...
Continue reading
In the July edition of Managing Intellectual Property Heike Röder-Hitschke discusses a significant European...
Continue reading
All publications
We are delighted to have been included in the Leaders League Rankings 2022 within the categories:
Continue reading
This year, the US publication Best Lawyers recommended 16 Maiwald attorneys as the best in their field. The Best Lawyers Ranking was published in the Handelsblatt Spezial – ...
Continue reading
All awards
Mon.
12
6th European Intellectual Property Forum (EIPF), is the largest leadership-level IP conference of its kind dedicated to bringing together a diverse set of audiences from all over the world including IP experts, owners and investors to discuss and find solutions for key issues and operational challenges faced by corporations and IP professionals today. The event will take p...
Continue reading
Thu.
30
This year, the Unitary Patent and the Unified Patent Court start, being a predominant change in the European patent terrain. The Unitary Patent and the Unified Patent Court raise new chances and opportunities and face law firms and clients with new challenges and questions. We are therefore pleased to invite you to
Continue reading
All events